DJIA 17,155.63 124.49 0.73%
NASDAQ 4,551.55 32.65 0.72%
S&P 500 2,002.07 17.94 0.90%
market minute promo

ImmunoGen (NASDAQ: IMGN)

11.15 0.16 (1.46%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

IMGN $11.15 1.46%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $11.06
Previous Close $10.99
Daily Range $10.86 - $11.20
52-Week Range $10.28 - $18.22
Market Cap $957.9M
P/E Ratio -13.24
Dividend (Yield) $0.00 (0.0%)
Volume 259,651
Average Daily Volume 734,769
Current FY EPS -$0.70





ImmunoGen (IMGN) Description

ImmunoGen develops cancer therapeutics through its tumor-activated, prodrug technology, which targets antibodies with cancer-killing drugs. Website:

News & Commentary

3 Beaten-Down Stocks Worth Buying

It isn't easy to find value in this market, but these three stocks could be making a strong case to rebound from their recent lows.

SEC Slaps Biotech Hedge Fund for Short-Selling Violations

ETF Rebalance Could Make 5 Biotech Stocks Shoot Higher

Trade-Ideas: Immunogen (IMGN) Is Today's Strong On High Relative Volume Stock

Why ImmunoGen (IMGN) Could Be Positioned for a Surge? - Tale of the Tape

Risk And Reward Seem Pretty Balanced At Seattle Genetics

ImmunoGen Q4 Loss Narrower than Expected, Provides Guidance - Analyst Blog

ImmunoGen's (IMGN) CEO Daniel Junius on Q4 2014 Results - Earnings Call Transcript

Q4 2014 Immunogen Inc Earnings Conference Call (Webcast)

Why ImmunoGen (IMGN) Might Surprise This Earnings Season - Tale of the Tape

Why ImmunoGen (IMGN) Might Surprise This Earnings Season - Tale of the Tape

See More IMGN News...

IMGN's Top Competitors

IMGN $11.15 (1.46%)
Current stock: IMGN
AMGN $138.79 (0.59%)
Current stock: AMGN
GILD $104.42 (3.40%)
Current stock: GILD
BIIB $327.19 (2.21%)
Current stock: BIIB